Order Article Reprints

Westley R, Casey F, Mitchell A, Alexander S, Nill S, Murray J, Ratnakumaran R, Pathmanathan A, Oelfke U, Dunlop A, et al. Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments. Cancers. 2024; 16(11):2073. https://doi.org/10.3390/cancers16112073

Westley, Rosalyne, Francis Casey, Adam Mitchell, Sophie Alexander, Simeon Nill, Julia Murray, Ragu Ratnakumaran, Angela Pathmanathan, Uwe Oelfke, Alex Dunlop, and et al. 2024. "Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments" Cancers 16, no. 11: 2073. https://doi.org/10.3390/cancers16112073

Westley, R., Casey, F., Mitchell, A., Alexander, S., Nill, S., Murray, J., Ratnakumaran, R., Pathmanathan, A., Oelfke, U., Dunlop, A., & Tree, A. C. (2024). Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments. Cancers, 16(11), 2073. https://doi.org/10.3390/cancers16112073